April 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altria Group, Inc. (“Altria” or “the Company”) (NYSE: MO). Investors who purchased Altria securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Altria has violated… read more
March 31, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grocery Outlet Holding Corp. (“Grocery Outlet” or “the Company”) (NASDAQ: GO). Investors who purchased Grocery Outlet securities prior to April 9, 2023, and continue to hold to the present, are encouraged… read more
March 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Vita Coco Company, Inc. (“Vita Coco” or “the Company”) (NASDAQ: COCO). Investors who purchased Vita Coco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
March 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmony Biosciences Holdings, Inc. (“Harmony” or “the Company”) (NASDAQ: HRMY). Investors who purchased Harmony securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmony has… read more
March 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Profound Medical Corp. (“Profound” or “the Company”) (NASDAQ: PROF). Investors who purchased Profound securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Profound has violated… read more
March 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xponential Fitness, Inc. (“Xponential” or “the Company”) (NYSE: XPOF). Investors who purchased Xponential securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Xponential has violated… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hesai Group (“Hesai” or “the Company”) (NASDAQ: HSAI). Investors who purchased Hesai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hesai has violated federal… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HealthEquity, Inc. (“HealthEquity” or “the Company”) (NASDAQ: HQY). Investors who purchased HealthEquity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HealthEquity has violated federal… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. (“RLX” or “the Company”) (NYSE: RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RLX has violated… read more
March 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Affirm Holdings, Inc. (“Affirm” or “the Company”) (NASDAQ: AFRM). Investors who purchased Affirm securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Affirm has violated… read more
March 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XP Inc. (“XP” or “the Company”) (NASDAQ: XP). Investors who purchased XP securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether XP has violated federal… read more
March 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OSI Systems, Inc. (“OSI” or “the Company”) (NASDAQ: OSIS). Investors who purchased OSI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OSI has violated… read more
March 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dave Inc. (“Dave” or “the Company”) (NASDAQ: DAVE). Investors who purchased Dave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dave has violated federal… read more
March 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XP Inc. (“XP” or “the Company”) (NASDAQ: XP). Investors who purchased XP securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether XP has violated federal… read more
March 13, 2025 |
test Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Nathan Miller 332-239-2660 | [email protected]
March 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH (“RH” or “the Company”) (NYSE: RH). Investors who purchased RH securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RH has violated federal securities… read more
March 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methanex Corporation (“Methanex” or “the Company”) (NASDAQ: MEOH). Investors who purchased Methanex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Methanex has violated federal… read more
March 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Robinhood Markets, Inc. (“Robinhood” or “the Company”) (NASDAQ: HOOD). Investors who purchased Robinhood securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Robinhood has violated… read more
March 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Caribou Biosciences, Inc. (“Caribou” or “the Company”) (NASDAQ: CRBU). Investors who purchased Caribou securities prior to July 14, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
March 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NVIDIA Corporation (“NVIDIA” or “the Company”) (NASDAQ: NVDA). Investors who purchased NVIDIA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NVIDIA has violated federal… read more
February 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CrowdStrike Holdings, Inc. (“CrowdStrike” or “the Company”) (NASDAQ: CRWD). Investors who purchased CrowdStrike securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CrowdStrike has violated… read more
February 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akamai Technologies, Inc. (“Akamai” or “the Company”) (NASDAQ: AKAM). Investors who purchased Akamai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Akamai has violated… read more
February 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Lion Electric Company (“Lion Electric” or “the Company”) (OTCMKTS: LEVGQ). Investors who purchased Lion Electric securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Parsons Corporation (“Parsons” or “the Company”) (NYSE: PSN). Investors who purchased Parsons securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Parsons has violated federal… read more
February 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Septerna, Inc. (“Septerna” or “the Company”) (NASDAQ: SEPN). Investors who purchased Septerna securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Septerna has violated federal… read more
February 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Synchrony Financial (“Synchrony” or “the Company”) (NYSE: SYF). Investors who purchased Synchrony securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Synchrony has violated federal… read more
February 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Barclays has violated federal… read more
February 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pliant Therapeutics, Inc. (“Pliant” or “the Company”) (NASDAQ: PLRX). Investors who purchased Pliant securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pliant has violated… read more
February 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ: STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether STAAR has violated… read more
February 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmonic Inc. (“Harmonic” or “the Company”) (NASDAQ: HLIT). Investors who purchased Harmonic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmonic has violated federal… read more